Achyuthan K E, Mary A, Greenberg C S
Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Biochem J. 1989 Jan 15;257(2):331-8. doi: 10.1042/bj2570331.
Ca(II) ions are crucial during proteolytic conversion of Factor XIII zymogen into the active enzyme Factor XIIIa. Factor XIII proteolyzed by thrombin or trypsin in the presence of 5 mM-EDTA resulted in rapid inactivation of transglutaminase activity. Factor XIIIa formed by thrombin or trypsin in the presence of 40 microM-Tb(III) ions, however, was indistinguishable from Factor XIIIa formed in the presence of 2-5 mM-Ca(II) ions with respect to molecular mass and transglutaminase activity. Thrombin treatment of Factor XIII in the presence of 1-5 microM-Tb(III) ions resulted in three fragments (76 kDa, 51 kDa and 19 kDa) with simultaneous loss of transglutaminase activity. Tb(III) ions at concentrations greater than 40 microM made platelet Factor XIII resistant to proteolysis by either thrombin or trypsin. Other lanthanide(III) ions [Ln(III) ions] tested [Ce(III), La(III) and Gd(III) ions] functioned similarly to Tb(III) ions during proteolytic activation of Factor XIII. Ln(III) ions (10-100 microM) were unable to replace the Ca(II) ions required for transglutaminase activity of Factor XIIIa. Tb(III) ions also inhibited in a non-competitive manner the transglutaminase activity of Factor XIIIa (Ki 71 microM) even when measured in the presence of 200-fold molar excess of Ca(II) ions. Factor XIII selectively bound to a Tb(III)-chelate affinity column, and could not be eluted by 100 mM-CaCl2. Binding of Tb(III) ions to Factor XIII was demonstrated by fluorescence emission due to Forster energy transfer. A 10(4)-fold molar excess of CaCl2, but not NaCl, partially quenched Tb(III) fluorescence. Low concentrations (5-20 microM) of Tb(III) ions also inhibited the binding of Factor XIII to des-A-fibrinogen by about 43%, whereas higher concentrations (40-100 microM) promoted binding. Conformational changes in Factor XIII consequent to the binding of Tb(III) ions could be responsible for the observed effects on protein structure and function.
钙离子在凝血因子 XIII 酶原向活性酶凝血因子 XIIIa 的蛋白水解转化过程中至关重要。在 5 mM - 乙二胺四乙酸(EDTA)存在的情况下,凝血酶或胰蛋白酶对凝血因子 XIII 的蛋白水解会导致转谷氨酰胺酶活性迅速失活。然而,在 40 μM - 铽(III)离子存在的情况下,凝血酶或胰蛋白酶形成的凝血因子 XIIIa 在分子量和转谷氨酰胺酶活性方面与在 2 - 5 mM - 钙离子存在时形成的凝血因子 XIIIa 并无区别。在 1 - 5 μM - 铽(III)离子存在的情况下,凝血酶对凝血因子 XIII 的处理产生了三个片段(76 kDa、51 kDa 和 19 kDa),同时转谷氨酰胺酶活性丧失。浓度大于 40 μM 的铽(III)离子使血小板凝血因子 XIII 对凝血酶或胰蛋白酶的蛋白水解具有抗性。测试的其他镧系(III)离子[铈(III)、镧(III)和钆(III)离子]在凝血因子 XIII 的蛋白水解激活过程中与铽(III)离子的作用相似。镧系(III)离子(10 - 100 μM)无法替代凝血因子 XIIIa 转谷氨酰胺酶活性所需的钙离子。即使在 200 倍摩尔过量的钙离子存在下进行测量,铽(III)离子也以非竞争性方式抑制凝血因子 XIIIa 的转谷氨酰胺酶活性(抑制常数 Ki 为 71 μM)。凝血因子 XIII 选择性地结合到铽(III)螯合亲和柱上,并且不能被 100 mM - 氯化钙洗脱。由于福斯特能量转移导致的荧光发射证明了铽(III)离子与凝血因子 XIII 的结合。10^4 倍摩尔过量的氯化钙而非氯化钠部分淬灭了铽(III)的荧光。低浓度(5 - 20 μM)的铽(III)离子也使凝血因子 XIII 与去 A - 纤维蛋白原的结合抑制约 43%,而较高浓度(40 - 100 μM)则促进结合。铽(III)离子结合导致的凝血因子 XIII 构象变化可能是观察到的对蛋白质结构和功能影响的原因。